stars 1 stars 2 stars 3

Meditech Access is a consulting firm specializing in Market Access, reimbursement and health economics for medical devices, in vitro diagnostics and innovative health technologies. Founded in 2012, we support MedTech companies in defining and implementing their Market Access strategies across Europe, with particular expertise in France and Belgium. Our expertise covers the entire Market Access pathway, from strategic planning to operational implementation: * Market Access & reimbursement strategy: assessing market opportunities, identifying reimbursement and funding pathways, and defining tailored access strategies. * Clinical evidence, HTA & health economics: identifying evidence requirements and supporting clinical and economic value demonstration. * Reimbursement dossiers & regulatory interactions: preparing and submitting reimbursement applications, and supporting companies throughout assessments, hearings and discussions with health authorities. Beyond strategic recommendations, we provide hands-on support to help MedTech companies navigate complex reimbursement environments and turn their Market Access strategies into concrete actions.

MediTech Access Questions

The MediTech Access annual revenue was $6.6 million in 2026.

Michel Verhasselt is the CEO and Founder Meditech Access SAS - Market Access EU of MediTech Access.

12 people are employed at MediTech Access.

MediTech Access is based in Versailles, Île-de-France.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users